Good post.
But does ACW have the skills and motivation to suddenly pivot from being a cognitive enhancement company to being a depressive disorders company?
Anyway, we must "follow the science".
- Forums
- ASX - By Stock
- ACW
- Ann: ACW XanaCIDD phase 2a trial topline results
Ann: ACW XanaCIDD phase 2a trial topline results, page-104
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $75.92M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 2.7¢ | $694.8K | 24.39M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 425457 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 1099237 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 425457 | 0.028 |
18 | 3249822 | 0.027 |
13 | 1782588 | 0.026 |
24 | 4563643 | 0.025 |
10 | 2745804 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 1099237 | 7 |
0.030 | 3946609 | 18 |
0.031 | 2721835 | 8 |
0.032 | 1231622 | 7 |
0.033 | 1265617 | 7 |
Last trade - 14.55pm 13/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online